Mar 16, 2022 / 12:40PM GMT
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good morning, and welcome to Day 2 of Oppenheimer's 32nd Annual Healthcare Conference. My name is Michael Wiederhorn. I'm the health care services analyst here. Today, we're hosting Chemed. We have President and CEO, Kevin McNamara; Chief Financial Officer, David Williams; President and CEO of VITAS, Nick Westfall. So today is going to be a fireside chat format for the audience. We should -- there should be a Q&A portal on the top right corner of your screen to submit questions, and feel free to use that function.
Questions and Answers:
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior AnalystSo good morning, guys. Thanks for coming. Thanks. And hopefully, this will be our last virtual hopefully, next year, we'll be back in person. Welcome. So I'll just kind of jump right into it here with kind of a broad question. Just kind of can you update us what you're seeing in terms of emissions and expenses trends post on